Utah Medical Products, Inc. (UTMD) to Issue Quarterly Dividend of $0.31 on July 3rd

Utah Medical Products, Inc. (NASDAQ:UTMD) declared a quarterly dividend on Tuesday, May 5th. Investors of record on Wednesday, June 17th will be paid a dividend of 0.31 per share by the medical instruments supplier on Friday, July 3rd. This represents a c) dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Wednesday, June 17th.

Utah Medical Products has increased its dividend by an average of 0.0%per year over the last three years and has increased its dividend every year for the last 3 years.

Utah Medical Products Trading Down 0.7%

Shares of NASDAQ UTMD opened at $64.41 on Thursday. The stock has a market cap of $204.82 million, a price-to-earnings ratio of 19.06 and a beta of 0.37. Utah Medical Products has a 1-year low of $52.00 and a 1-year high of $71.81. The stock’s 50-day moving average is $65.45 and its 200 day moving average is $61.22.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. The company had revenue of $8.72 million for the quarter. Utah Medical Products had a return on equity of 9.17% and a net margin of 28.90%.

Hedge Funds Weigh In On Utah Medical Products

Several institutional investors and hedge funds have recently bought and sold shares of UTMD. Brandes Investment Partners LP grew its position in Utah Medical Products by 4.0% during the 4th quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock worth $19,660,000 after acquiring an additional 13,392 shares during the last quarter. Segall Bryant & Hamill LLC bought a new position in Utah Medical Products during the 3rd quarter worth approximately $726,000. Quantinno Capital Management LP bought a new position in Utah Medical Products during the 2nd quarter worth approximately $608,000. Ritholtz Wealth Management grew its position in Utah Medical Products by 168.5% during the 1st quarter. Ritholtz Wealth Management now owns 14,807 shares of the medical instruments supplier’s stock worth $918,000 after acquiring an additional 9,293 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in Utah Medical Products by 6.5% during the 2nd quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock worth $6,537,000 after acquiring an additional 7,040 shares during the last quarter. 69.60% of the stock is currently owned by institutional investors.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).